Ero Copper Announces 2025 Results; Critical Scrutiny Needed on Execution and Valuation

What happened

Ero Copper has reported its fourth quarter and full-year 2025 operating and financial results, with a conference call scheduled for tomorrow. This follows a year where the stock surged 170% to $36.88, driven by copper price momentum and optimistic growth expectations from the Tucumã project ramp-up. However, the DeepValue report highlights significant execution risks, including past guidance cuts and cost overruns at Tucumã, where C1 costs rose to $1.62/lb in Q3 2025, above initial targets. Valuation remains elevated at 27.8x P/E and 22.97x EV/EBITDA, with net debt/EBITDA at 2.97, indicating little margin of safety for investors. The results will be closely watched for evidence of sustainable production volumes and cost control to justify the current price.

Implication

The announcement triggers a critical evaluation of whether 2025 production met the revised guidance of 67.5–80 kt copper and if costs are aligning with the updated $1.35–1.55/lb range at Tucumã. High multiples leave no room for error; any shortfall in volumes or further cost overruns could compress the stock towards the base case value of $32, representing significant downside risk. Market sentiment has become crowded on the upside, but early stress signals like past earnings misses suggest vulnerability to operational hiccups or copper price normalization. Strong results might temporarily support the bull case, but structural concerns such as leverage and ongoing capital needs for projects like Furnas remain. Ultimately, the investment case hinges on upcoming 2026 guidance and the H1 2026 Furnas PEA, making this release a pivotal checkpoint for reassessing exposure.

Thesis delta

The DeepValue report's thesis of a 'POTENTIAL SELL' due to high valuation and execution risks remains unchanged pending the detailed results. If the 2025 outcomes confirm ongoing challenges like cost creep or production shortfalls, the thesis is reinforced; if they show improvement, reassessment may be warranted, but current price still embeds optimistic assumptions that require flawless execution.